Definitive Net Receivables from 2010 to 2026

DH Stock  USD 1.28  0.12  8.57%   
Definitive Healthcare's Net Receivables is increasing with slightly volatile movements from year to year. Net Receivables is predicted to flatten to about 51 M. For the period between 2010 and 2026, Definitive Healthcare, Net Receivables quarterly trend regression had mean deviation of  12,414,761 and range of 34.2 M. View All Fundamentals
 
Net Receivables  
First Reported
2020-12-31
Previous Quarter
34.9 M
Current Value
52 M
Quarterly Volatility
11 M
 
Covid
 
Interest Hikes
Check Definitive Healthcare financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Definitive Healthcare's main balance sheet or income statement drivers, such as Depreciation And Amortization of 39.9 M, Interest Expense of 15.2 M or Selling General Administrative of 42.3 M, as well as many indicators such as Price To Sales Ratio of 1.2, Dividend Yield of 0.0051 or PTB Ratio of 0.77. Definitive financial statements analysis is a perfect complement when working with Definitive Healthcare Valuation or Volatility modules.
  
Build AI portfolio with Definitive Stock
Check out the analysis of Definitive Healthcare Correlation against competitors.
The Net Receivables trend for Definitive Healthcare Corp offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether Definitive Healthcare is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.

Latest Definitive Healthcare's Net Receivables Growth Pattern

Below is the plot of the Net Receivables of Definitive Healthcare Corp over the last few years. It is Definitive Healthcare's Net Receivables historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Definitive Healthcare's overall financial position and show how it may be relating to other accounts over time.
Net Receivables10 Years Trend
Slightly volatile
   Net Receivables   
       Timeline  

Definitive Net Receivables Regression Statistics

Arithmetic Mean35,349,406
Geometric Mean33,075,815
Coefficient Of Variation39.37
Mean Deviation12,414,761
Median25,021,000
Standard Deviation13,916,617
Sample Variance193.7T
Range34.2M
R-Value0.84
Mean Square Error61.2T
R-Squared0.70
Significance0.000026
Slope2,312,233
Total Sum of Squares3098.8T

Definitive Net Receivables History

202651 M
202552 M
202453.2 M
202359.2 M
202258.8 M
202143.3 M
202033.1 M

About Definitive Healthcare Financial Statements

Investors use fundamental indicators, such as Definitive Healthcare's Net Receivables, to determine how well the company is positioned to perform in the future. Although Definitive Healthcare's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
Net Receivables52 M51 M

Currently Active Assets on Macroaxis

Check out the analysis of Definitive Healthcare Correlation against competitors.
You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Is there potential for Health Care Technology market expansion? Will Definitive introduce new products? Factors like these will boost the valuation of Definitive Healthcare. Projected growth potential of Definitive fundamentally drives upward valuation adjustments. Understanding fair value requires weighing current performance against future potential. All the valuation information about Definitive Healthcare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.72)
Revenue Per Share
2.265
Quarterly Revenue Growth
(0.01)
Return On Assets
(0.01)
Return On Equity
(0.40)
The market value of Definitive Healthcare is measured differently than its book value, which is the value of Definitive that is recorded on the company's balance sheet. Investors also form their own opinion of Definitive Healthcare's value that differs from its market value or its book value, called intrinsic value, which is Definitive Healthcare's true underlying value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Because Definitive Healthcare's market value can be influenced by many factors that don't directly affect Definitive Healthcare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between Definitive Healthcare's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Definitive Healthcare should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Definitive Healthcare's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.